Literature DB >> 24924605

The impact of familial Mediterranean fever on reproductive system.

Muyesser Nergiz Yanmaz1, Ayşet Jane Özcan, Kadir Savan.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent attacks of fever, peritonitis, pleuritis, arthritis, or erysipelas-like skin lesion. FMF is the most common periodic febrile syndrome affecting more than 150,000 people worldwide. The majority of patients develop FMF before the age of 20. FMF may cause amyloidosis, which mainly affects the kidneys but may also be accumulated in other organs such as the heart, gastrointestinal tract, and reproductive organs. FMF being a systemic disorder with a risk for amyloidosis, affecting patients in their childbearing years, and with its lifelong colchicine therapy raises concern about its effect on the reproductive system. In this article, we review the impact of FMF and its treatment to the reproductive system of male and female patients, pregnancy, and lactation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24924605     DOI: 10.1007/s10067-014-2709-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis.

Authors:  E Ben-Chetrit; R Backenroth; R Haimov-Kochman; G Pizov
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

2.  Azoospermia caused by colchicine--a case report.

Authors:  H E Merlin
Journal:  Fertil Steril       Date:  1972-03       Impact factor: 7.329

3.  Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?

Authors:  Eli Ben-Chetrit; Avraham Ben-Chetrit; Yackov Berkun; Eldad Ben-Chetrit
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

4.  The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design.

Authors:  V Cobankara; G Fidan; T Türk; M Zencir; M Colakoglu; S Ozen
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

5.  Colchicine inhibits spermatozoal motility in vitro.

Authors:  A Ben-Chetrit; E Ben-Chetrit; R Nitzan; M Ron
Journal:  Int J Fertil Menopausal Stud       Date:  1993 Sep-Oct

6.  Interaction of tubulin with single ring analogues of colchicine.

Authors:  J M Andreu; S N Timasheff
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

7.  Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects.

Authors:  T F YU; A B GUTMAN
Journal:  Ann Intern Med       Date:  1961-08       Impact factor: 25.391

8.  No appreciable decrease in fertility in Behçet's syndrome.

Authors:  Didem Uzunaslan; Caner Saygin; Gulen Hatemi; Koray Tascilar; Hasan Yazici
Journal:  Rheumatology (Oxford)       Date:  2013-12-24       Impact factor: 7.580

9.  Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery.

Authors:  Danielle Ofir; Amalia Levy; Arnon Wiznitzer; Moshe Mazor; Eyal Sheiner
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-09-03       Impact factor: 2.435

10.  The effects of long-term colchicine therapy on male fertility in patients with familial Mediterranean fever.

Authors:  M Ehrenfeld; M Levy; E J Margalioth; M Eliakim
Journal:  Andrologia       Date:  1986 Jul-Aug       Impact factor: 2.775

View more
  5 in total

1.  [IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever].

Authors:  N Venhoff; R E Voll; C Glaser; J Thiel
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

2.  Familial Mediterranean fever-associated infertility and underlying factors.

Authors:  Nuh Atas; Berkan Armagan; Erdal Bodakci; Hasan Satis; Alper Sari; Nazife Sule Yasar Bilge; Reyhan Bilici Salman; Gozde Kubra Yardımcı; Hakan Babaoglu; Levent Kilic; Mehmet Akif Ozturk; Berna Goker; Seminur Haznedaroglu; Timucin Kasifoglu; Umut Kalyoncu; Abdurrahman Tufan
Journal:  Clin Rheumatol       Date:  2019-09-09       Impact factor: 2.980

3.  International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors.

Authors:  Taryn Youngstein; Patrycja Hoffmann; Ahmet Gül; Thirusha Lane; Rene Williams; Dorota M Rowczenio; Huri Ozdogan; Serdal Ugurlu; John Ryan; Len Harty; Sean Riminton; Alex P Headley; Joachim Roesler; Norbert Blank; Jasmin B Kuemmerle-Deschner; Anna Simon; Adrian S Woolf; Philip N Hawkins; Helen J Lachmann
Journal:  Rheumatology (Oxford)       Date:  2017-12-01       Impact factor: 7.580

4.  Episode of Familial Mediterranean Fever-Related Peritonitis in the Second Trimester of Pregnancy Followed by Acute Cholecystitis: Dilemmas and Pitfalls.

Authors:  Christophoros Kosmidis; Georgios Anthimidis; Nikolaos Varsamis; Fotini Makedou; Eleni Georgakoudi; Christophoros Efthimiadis
Journal:  Am J Case Rep       Date:  2016-02-24

Review 5.  Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans.

Authors:  Raffaele Manna; Donato Rigante
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 3.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.